Explore/

Cannabis Stocks

Cannabis Stocks

39.41k followers23 symbols +5.41% Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

23 symbols

To view the complete list, get the Yahoo Finance app

Get the Yahoo Finance app

  • Free real-time data
  • News and price alerts
  • Add and edit holdings
  • Track performance
  • Create multiple watchlists
  • Here's Why AbbVie Stock Surged 21.1% in November
    Motley Fool9 hours ago

    Here's Why AbbVie Stock Surged 21.1% in November

    Hints of success for the company's blood cancer pipeline encouraged investors last month.

  • The Craziest Marijuana Statistic of 2018
    Motley Fool14 hours ago

    The Craziest Marijuana Statistic of 2018

    Despite no shortage of cannabis milestones, it was an odd year for pot stocks.

  • 2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb
    Motley Fool17 hours ago

    2 Must-Read Quotes on Marijuana From FDA Head Scott Gottlieb

    Is cannabis policy reform at the federal level "inevitable?"

  • 3 Top Stocks to Buy in December
    Motley Fool17 hours ago

    3 Top Stocks to Buy in December

    These stocks have one common denominator: Great long-term growth prospects.

  • Why Aurora Cannabis, Canopy Growth, and Tilray Have Had a Better Year Than You Might Think
    Motley Fool17 hours ago

    Why Aurora Cannabis, Canopy Growth, and Tilray Have Had a Better Year Than You Might Think

    There's more to the story for these Canadian marijuana stocks' gains -- or lack thereof -- in 2018.

  • Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals
    Motley Fool17 hours ago

    Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals

    Which stock wins in a matchup between this top Canadian marijuana grower and the biggest cannabis-focused biotech?

  • Did Gilead Sciences Make an $11 Billion Blunder?
    Motley Fool19 hours ago

    Did Gilead Sciences Make an $11 Billion Blunder?

    Spoiler alert: The answer is "no."

  • Here's Why Scotts Miracle-Gro Rose 13.8% in November
    Motley Foolyesterday

    Here's Why Scotts Miracle-Gro Rose 13.8% in November

    The home garden specialist announced fiscal 2018 earnings and issued upbeat guidance for fiscal 2019.

  • Better Marijuana Stock: Aurora Cannabis vs. KushCo Holdings
    Motley Fool2 days ago

    Better Marijuana Stock: Aurora Cannabis vs. KushCo Holdings

    Which stock wins in a matchup between a big marijuana producer and a top ancillary products supplier to the cannabis industry?

  • 4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt
    Motley Fool2 days ago

    4 Multibillion-Dollar Industries Canopy Growth Thinks It Will Disrupt

    Are Canopy's plans to jump into multiple huge markets only pipe dreams? Not at all.

  • A look at where companies stand on marijuana business
    Associated Press2 days ago

    A look at where companies stand on marijuana business

    When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry — and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, but the South American country's market is dwarfed by Canada's. And while a majority of U.S. states have legalized marijuana to varying degrees, contradictory federal laws have U.S. companies reluctant to invest here. — Marlboro maker Altria Group Inc., which is headquartered in Richmond, Virginia, is paying $1.8 billion for a 45 percent stake in Cronos Group.

  • Better Buy: Scotts Miracle-Gro vs. Lowe's
    Motley Fool2 days ago

    Better Buy: Scotts Miracle-Gro vs. Lowe's

    There are two factors to consider when looking at Lowe's and Miracle-Gro: recent performance and marijuana.

  • A Look at AbbVie’s Earnings Projections for 2018
    Market Realist2 days ago

    A Look at AbbVie’s Earnings Projections for 2018

    On its third-quarter earnings conference call, AbbVie (ABBV) raised its adjusted EPS guidance for 2018 from its previous projection of $7.76–$7.86 to $7.90–$7.92. The revised estimate implies a YoY (year-over-year) rise of 41.3% considering the midpoint of the guidance range. As per the company’s third-quarter earnings conference call, AbbVie expects its adjusted fourth-quarter EPS to be in the range of $1.89–$1.91 excluding a $0.26 impact of noncash amortization and other items.

  • Why Aphria Tanked Over 11% Today
    Market Realist2 days ago

    Why Aphria Tanked Over 11% Today

    Today, Aphria (APHA)(APHQF) resumed a sharp sell-off in its stock from early this month after surging a whopping 51% yesterday. Now, let’s find out what could be driving Aphria stock down today. Grego alleged that “Aphria had diverted funds into inflated investments held by insiders.” Since then, these allegations have taken a massive toll on investors’ confidence.

  • Stocks tumble, crude oil surges on OPEC deal
    Yahoo Finance2 days ago

    Stocks tumble, crude oil surges on OPEC deal

    Stock got slammed on Friday, and crude oil surged on an OPEC deal.

  • Assessing AbbVie’s 2018 Revenue Projections
    Market Realist2 days ago

    Assessing AbbVie’s 2018 Revenue Projections

    On its third-quarter earnings conference call, AbbVie (ABBV) raised its net revenue guidance for 2018 from its previous projection of $32.5 billion to $32.7 billion. The company also raised its forecast for YoY (year-over-year) operational revenue growth in 2018 from 14.5% to 15.0%. As per AbbVie’s third-quarter earnings conference call, the company expects a favorable revenue impact of less than 1% due to foreign currency fluctuations in 2018.

  • Marlboro maker places $1.8 billion bet on marijuana
    Associated Press2 days ago

    Marlboro maker places $1.8 billion bet on marijuana

    One of the world's biggest tobacco companies is diving into the cannabis market with a $1.8 billion buy-in. Marlboro maker Altria Group Inc. is taking a 45 percent stake in Cronos Group, the Canadian medical and recreational marijuana provider said Friday. The agreement includes a warrant to acquire additional shares over the next four years that could give the Altria, which is based in Richmond, Virginia, a 55 percent ownership stake in the Toronto company.

  • Analysts’ Recommendations for AbbVie in December
    Market Realist2 days ago

    Analysts’ Recommendations for AbbVie in December

    The company saw a rise of 17.53% in its share price from $80.21 on November 1 to $94.27 on November 30. Thereafter, AbbVie saw a 3.95% fall in its share price from November 30 to December 5. On November 30, AbbVie issued a press release announcing agreements that granted Pfizer (PFE) a nonexclusive global license related to Humira’s intellectual property.

  • Investing.com2 days ago

    AbbVie Falls 4%

    Investing.com - AbbVie (NYSE:ABBV) fell by 4.11% to trade at $86.620 by 11:29 (16:29 GMT) on Friday on the NYSE exchange.

  • Short Seller Not Backing Down on Aphria
    Market Realist3 days ago

    Short Seller Not Backing Down on Aphria

    On December 6, Aphria’s (APHQF) short seller, Hindenburg Research, released its Part 2 on what it found to be further malice in the company’s acquisition efforts. According to the research, this acquisition showed a 5 million Canadian dollar gain to Aphria’s insider in a matter of six days. Further, the report pointed out that Aphria’s CEO, Vic Neufeld, was also a part of the “discount round” in which Aphria purchased companies at overpriced valuations. Even more damning was the short seller’s observation that the SEC had alleged that the individuals that Aphria purchased companies from were involved in pump and dump schemes.

  • Weed CEO: 'Edibles suffer from 3 major problems'
    Yahoo Finance3 days ago

    Weed CEO: 'Edibles suffer from 3 major problems'

    Edibles still quite aren't mainstream for various reasons, an edibles CEO tells Yahoo Finance recently on the Final Round.

  • Stocks tumble, oil surges on OPEC deal
    Yahoo Finance3 days ago

    Stocks tumble, oil surges on OPEC deal

    Yahoo Finance's LIVE market coverage and analysis, beginning each day at 11:30 a.m. ET.

  • Aphria’s Announcement of Special Committee Pauses Sell-Off
    Market Realist3 days ago

    Aphria’s Announcement of Special Committee Pauses Sell-Off

    Aprhia (APHQF) recovered by nearly 50% on December 6 due to its further commitment to relieve investors’ fears related to its Latin America business. The company appointed a special committee that consists of independent directors who will be tasked with reviewing the legitimacy of the company’s acquisitions in Latin America. The above chart shows that Aphria (APHQF) is among the top ten holdings in the Horizons Marijuana Life Sciences ETF (HMMJ).

  • Market Realist3 days ago

    It’s Official: Altria Acquires a Stake in Cronos Group

    On December 7, Altria officially announced that it acquired a ~45% stake in the company to the tune of $1.8 billion. Given that Altria has been in the tobacco business for nearly three decades, the cannabis business makes sense for the business.